Connection

Kit Simpson to United States

This is a "connection" page, showing publications Kit Simpson has written about United States.
Connection Strength

2.335
  1. Measuring Value: Cost-Effectiveness Analysis for Occupational Therapy. Am J Occup Ther. 2022 Jan 01; 76(1).
    View in: PubMed
    Score: 0.083
  2. Measuring the impact of the Affordable Care Act Medicaid expansion on access to primary care using an interrupted time series approach. Health Res Policy Syst. 2021 May 06; 19(1):77.
    View in: PubMed
    Score: 0.079
  3. Disparities in Bariatric Surgery Utilization in Underserved Diabetes Populations. J Health Care Poor Underserved. 2020; 31(2):530-537.
    View in: PubMed
    Score: 0.072
  4. Using Inferred Mobility Status to Estimate the Time to Major Depressive Disorder Diagnosis Post-Spinal Cord Injury. Arch Phys Med Rehabil. 2020 04; 101(4):658-666.
    View in: PubMed
    Score: 0.072
  5. Increased Nonexudative Age-Related Macular Degeneration Diagnosis Among Medicare Beneficiaries With Rheumatoid Arthritis. Invest Ophthalmol Vis Sci. 2019 08 01; 60(10):3520-3526.
    View in: PubMed
    Score: 0.070
  6. Loop diuretic use among patients with heart failure and type 2 diabetes treated with sodium glucose cotransporter-2 inhibitors. J Diabetes Complications. 2019 08; 33(8):567-571.
    View in: PubMed
    Score: 0.069
  7. The Effect of Frailty on Discharge Location for Medicare Beneficiaries After Acute Stroke. Arch Phys Med Rehabil. 2019 07; 100(7):1317-1323.
    View in: PubMed
    Score: 0.068
  8. Effect of frailty on resource use and cost for Medicare patients. J Comp Eff Res. 2018 08; 7(8):817-825.
    View in: PubMed
    Score: 0.065
  9. Polypharmacy and adverse drug events among propensity score?matched privately insured persons with and without spinal cord injury. Spinal Cord. 2018 06; 56(6):591-597.
    View in: PubMed
    Score: 0.063
  10. Stroke Administrative Severity Index: using administrative data for 30-day poststroke outcomes prediction. J Comp Eff Res. 2018 04; 7(4):293-304.
    View in: PubMed
    Score: 0.062
  11. Observed Cost and Variations in Short Term Cost-Effectiveness of Therapy for Ischemic Stroke in Interventional Management of Stroke (IMS) III. J Am Heart Assoc. 2017 May 08; 6(5).
    View in: PubMed
    Score: 0.060
  12. The Monetary Cost of Sexual Assault to Privately Insured US Women in 2013. Am J Public Health. 2017 06; 107(6):983-988.
    View in: PubMed
    Score: 0.060
  13. Bariatric surgery implementation trends in the USA from 2002 to 2012. Implement Sci. 2016 Feb 20; 11:21.
    View in: PubMed
    Score: 0.055
  14. A Severe Sepsis Mortality Prediction Model and Score for Use With Administrative Data. Crit Care Med. 2016 Feb; 44(2):319-27.
    View in: PubMed
    Score: 0.055
  15. Effect of the Economic Recession on Primary Care Access for the Homeless. J Health Care Poor Underserved. 2016; 27(3):1577-91.
    View in: PubMed
    Score: 0.055
  16. Opioid Prescribing and Potential Overdose Errors Among Children 0 to 36 Months Old. Clin Pediatr (Phila). 2015 Jul; 54(8):738-44.
    View in: PubMed
    Score: 0.052
  17. Preventable hospital admissions among the homeless in California: a retrospective analysis of care for ambulatory care sensitive conditions. BMC Health Serv Res. 2014 Oct 25; 14:511.
    View in: PubMed
    Score: 0.050
  18. Discharge disposition after bariatric surgery. Obes Surg. 2014 Oct; 24(10):1821-5.
    View in: PubMed
    Score: 0.050
  19. HIV economic burden of illness in the Veterans Health Administration population. AIDS Care. 2015; 27(1):123-31.
    View in: PubMed
    Score: 0.050
  20. The one-year attributable cost of post-stroke dysphagia. Dysphagia. 2014 Oct; 29(5):545-52.
    View in: PubMed
    Score: 0.049
  21. Cost-effectiveness analysis of annual Trichomonas vaginalis screening and treatment in HIV-positive women to prevent HIV transmission. Sex Transm Dis. 2014 Jun; 41(6):353-8.
    View in: PubMed
    Score: 0.049
  22. Cost of treatment in a US commercially insured, HIV-1-infected population. PLoS One. 2014; 9(5):e98152.
    View in: PubMed
    Score: 0.049
  23. Costs of adverse events among patients with HIV infection treated with nonnucleoside reverse transcriptase inhibitors. HIV Med. 2014 Sep; 15(8):488-98.
    View in: PubMed
    Score: 0.048
  24. Lopinavir/ritonavir versus darunavir plus ritonavir for HIV infection: a cost-effectiveness analysis for the United States. Pharmacoeconomics. 2013 May; 31(5):427-44.
    View in: PubMed
    Score: 0.045
  25. The cost of Medicaid savings: the potential detrimental public health impact of neonatal circumcision defunding. Infect Dis Obstet Gynecol. 2012; 2012:540295.
    View in: PubMed
    Score: 0.044
  26. A cost-effectiveness analysis of anal cancer screening in HIV-positive women. J Low Genit Tract Dis. 2012 Jul; 16(3):275-80.
    View in: PubMed
    Score: 0.043
  27. The one-year attributable cost of poststroke aphasia. Stroke. 2012 May; 43(5):1429-31.
    View in: PubMed
    Score: 0.042
  28. Hospital care for patients experiencing weekend vs weekday stroke: a comparison of quality and aggressiveness of care. Arch Neurol. 2010 Jan; 67(1):39-44.
    View in: PubMed
    Score: 0.036
  29. Cost-effectiveness analysis of lopinavir/ritonavir and atazanavir+ritonavir regimens in the CASTLE study. Adv Ther. 2009 Feb; 26(2):185-93.
    View in: PubMed
    Score: 0.034
  30. Cost-effectiveness of tipranavir in treatment-experienced HIV patients in the United States. HIV Clin Trials. 2008 Jul-Aug; 9(4):225-37.
    View in: PubMed
    Score: 0.032
  31. Cost-effectiveness of extended adjuvant rituximab for US patients aged 65-70 years with follicular lymphoma in second remission. Clin Lymphoma Myeloma. 2008 Jun; 8(3):166-70.
    View in: PubMed
    Score: 0.032
  32. Cost effectiveness of lopinavir/ritonavir compared with atazanavir plus ritonavir in antiretroviral-experienced patients in the US. Clin Drug Investig. 2007; 27(7):443-52.
    View in: PubMed
    Score: 0.029
  33. Comparison of self-report versus agency records of service utilization in a community sample of individuals with alcohol use disorders. Drug Alcohol Depend. 2004 Feb 07; 73(2):141-7.
    View in: PubMed
    Score: 0.024
  34. Incidence of Poststroke Depression in Patients With Poststroke Dysphagia. Am J Speech Lang Pathol. 2022 07 12; 31(4):1836-1844.
    View in: PubMed
    Score: 0.021
  35. Dabigatran and Wet AMD, Results From Retinal Pigment Epithelial Cell Monolayers, the Mouse Model of Choroidal Neovascularization, and Patients From the Medicare Data Base. Front Immunol. 2022; 13:896274.
    View in: PubMed
    Score: 0.021
  36. Determining Factors that Influence Adoption of New Post-Stroke Sensorimotor Rehabilitation Devices in the USA. IEEE Trans Neural Syst Rehabil Eng. 2021; 29:1213-1222.
    View in: PubMed
    Score: 0.020
  37. Patterns of dispensed opioids after tonsillectomy in children and adolescents in South Carolina, United States, 2010-2017. Int J Pediatr Otorhinolaryngol. 2021 Apr; 143:110636.
    View in: PubMed
    Score: 0.019
  38. Modeling the use of triple combination therapy in five countries: nevirapine, Zidovudine, and Didanosine. Value Health. 2000 May-Jun; 3(3):186-201.
    View in: PubMed
    Score: 0.018
  39. Beyond acute stroke: Rate of stroke transfers to a tertiary centre following the implementation of a dedicated inpatient teleneurology network. J Telemed Telecare. 2021 May; 27(4):239-243.
    View in: PubMed
    Score: 0.018
  40. A Longitudinal Examination of the Asthma Medication Ratio in Children with Medicaid. J Asthma. 2020 10; 57(10):1083-1091.
    View in: PubMed
    Score: 0.017
  41. A new side of sarcoidosis: medication and hospitalization use in a privately insured patient population. Sarcoidosis Vasc Diffuse Lung Dis. 2019; 36(2):124-129.
    View in: PubMed
    Score: 0.017
  42. Sexually transmitted infections in privately insured adults with intellectual and developmental disabilities. J Comp Eff Res. 2019 06; 8(8):599-606.
    View in: PubMed
    Score: 0.017
  43. Pathologic Specimens at Time of Pyeloplasty: Frequency and Practice Patterns. Urology. 2018 Dec; 122:158-161.
    View in: PubMed
    Score: 0.016
  44. The cost-effectiveness of treatment with lamivudine and zidovudine compared with zidovudine alone: a comparison of Markov model and trial data estimates. Am J Manag Care. 1998 Jul; 4(7):1004-12.
    View in: PubMed
    Score: 0.016
  45. Out-of-pocket medical expenses in severe CHD. Cardiol Young. 2018 Aug; 28(8):1014-1018.
    View in: PubMed
    Score: 0.016
  46. A longitudinal examination of the asthma medication ratio in children. Am J Manag Care. 2018 06; 24(6):294-300.
    View in: PubMed
    Score: 0.016
  47. Utilization of Outpatient Telehealth Services in Parity and Nonparity States 2010-2015. Telemed J E Health. 2019 02; 25(2):132-136.
    View in: PubMed
    Score: 0.016
  48. Healthcare Costs for Insured Older U.S. Adults with Hearing Loss. J Am Geriatr Soc. 2018 08; 66(8):1546-1552.
    View in: PubMed
    Score: 0.016
  49. Current Trends in the Use of Shoulder Arthroplasty in the United States. Orthopedics. 2018 May 01; 41(3):e416-e423.
    View in: PubMed
    Score: 0.016
  50. Constipation-Related Emergency Department Use, and Associated Office Visits and Payments Among Commercially Insured Children. Acad Pediatr. 2018 Nov - Dec; 18(8):952-956.
    View in: PubMed
    Score: 0.016
  51. Comparing Disability Levels for Community-dwelling Adults in the United States and the Republic of Korea using the Rasch Model. J Appl Meas. 2018; 19(2):114-128.
    View in: PubMed
    Score: 0.016
  52. FIM-Minimum Data Set Motor Item Bank: Short Forms Development and Precision Comparison in Veterans. Arch Phys Med Rehabil. 2018 03; 99(3):534-541.e2.
    View in: PubMed
    Score: 0.015
  53. Patient and Hospital Characteristics Associated with Interhospital Transfer for Adults with Ventilator-Dependent Respiratory Failure. Ann Am Thorac Soc. 2017 May; 14(5):730-736.
    View in: PubMed
    Score: 0.015
  54. Linking Existing Instruments to Develop an Activity of Daily Living Item Bank. Eval Health Prof. 2018 03; 41(1):25-43.
    View in: PubMed
    Score: 0.015
  55. Where You Live Matters: The Impact of Place of Residence on Severe Sepsis Incidence and Mortality. Chest. 2016 Oct; 150(4):829-836.
    View in: PubMed
    Score: 0.014
  56. Higher Health Care Costs in Middle-aged US Adults With Hearing Loss. JAMA Otolaryngol Head Neck Surg. 2016 06 01; 142(6):607-9.
    View in: PubMed
    Score: 0.014
  57. Is POCT cost effective for coronary bypass patients in ICUs? MLO Med Lab Obs. 1996 Feb; 28(2):58-62.
    View in: PubMed
    Score: 0.014
  58. A model for estimating the impact of changes in children's vaccines. Am J Public Health. 1995 Dec; 85(12):1666-72.
    View in: PubMed
    Score: 0.014
  59. Health-care expenditures for tuberculosis in the United States. Arch Intern Med. 1995 Aug 7-21; 155(15):1595-600.
    View in: PubMed
    Score: 0.013
  60. Impact of Outpatient Rehabilitation Medicare Reimbursement Caps on Utilization and Cost of Rehabilitation Care After Ischemic Stroke: Do Caps Contain Costs? Arch Phys Med Rehabil. 2015 Nov; 96(11):1959-65.e4.
    View in: PubMed
    Score: 0.013
  61. Frequency, cost, and risk factors of readmissions among severe sepsis survivors. Crit Care Med. 2015 Apr; 43(4):738-46.
    View in: PubMed
    Score: 0.013
  62. Burden of nonnucleoside reverse transcriptase inhibitor resistance in HIV-1-infected patients: a systematic review and meta-analysis. AIDS Res Hum Retroviruses. 2014 Aug; 30(8):753-68.
    View in: PubMed
    Score: 0.012
  63. Association of electronic health records with cost savings in a national sample. Am J Manag Care. 2014 Jun 01; 20(6):e183-90.
    View in: PubMed
    Score: 0.012
  64. Drivers of costs associated with reperfusion therapy in acute stroke: the Interventional Management of Stroke III Trial. Stroke. 2014 Jun; 45(6):1791-8.
    View in: PubMed
    Score: 0.012
  65. Cost-minimization comparison of darunavir plus ritonavir and lopinavir/ritonavir in HIV-1 infected treatment-na?ve women of childbearing age. J Med Econ. 2014 Apr; 17(4):250-8.
    View in: PubMed
    Score: 0.012
  66. Indices for monitoring hospital outcomes in developed countries. Health Policy. 1992 May; 21(1):1-15.
    View in: PubMed
    Score: 0.011
  67. Informing the mammography coverage debate. Results of meta-analysis, computer modeling, and issue analysis. Int J Technol Assess Health Care. 1991; 7(4):616-31.
    View in: PubMed
    Score: 0.010
  68. Piloting a method to measure satisfaction with HIV care. Am J Med Qual. 2010 Sep-Oct; 25(5):384-91.
    View in: PubMed
    Score: 0.009
  69. Cost-utility of treatments for pulmonary arterial hypertension: a Markov state-transition decision analysis model. Clin Drug Investig. 2009; 29(10):635-46.
    View in: PubMed
    Score: 0.008
  70. Design of the economic evaluation for the Interventional Management of Stroke (III) trial. Int J Stroke. 2008 May; 3(2):138-44.
    View in: PubMed
    Score: 0.008
  71. Do diabetes group visits lead to lower medical care charges? Am J Manag Care. 2008 Jan; 14(1):39-44.
    View in: PubMed
    Score: 0.008
  72. A markov model of the cost effectiveness of olanzapine treatment for agitation and psychosis in Alzheimer's disease. Clin Drug Investig. 2008; 28(5):291-303.
    View in: PubMed
    Score: 0.008
  73. Insurance barriers for childhood survivors of pediatric brain tumors: the case for neurocognitive evaluations. Pediatr Neurosurg. 2006; 42(4):223-7.
    View in: PubMed
    Score: 0.007
  74. Economic decision analysis model of screening for lung cancer. Eur J Cancer. 2001 Sep; 37(14):1759-67.
    View in: PubMed
    Score: 0.005
  75. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing. Am J Gastroenterol. 2000 Nov; 95(11):3250-8.
    View in: PubMed
    Score: 0.005
  76. The economic and clinical efficiency of point-of-care testing for critically ill patients: a decision-analysis model. Am J Med Qual. 1998; 13(1):3-12.
    View in: PubMed
    Score: 0.004
  77. Variations in practice patterns: antiviral drug use in hospitalized patients with herpes infections. Am J Med Qual. 1996; 11(1):33-42.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.